tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Mangoceuticals Launches $100 Million Solana Treasury Strategy

Story Highlights
  • Mango DAT signed a December 17, 2025 deal with Cube Group for Solana custody and discretionary asset management under a tiered fee structure.
  • On December 19, 2025 Mangoceuticals launched an up to $100 million Solana-focused treasury strategy to drive non-dilutive, yield-based growth and expand into broader digital asset initiatives.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Mangoceuticals Launches $100 Million Solana Treasury Strategy

Claim 70% Off TipRanks This Holiday Season

Mangoceuticals, Inc. ( (MGRX) ) has shared an announcement.

On December 17, 2025, Mangoceuticals’ subsidiary Mango DAT, LLC entered into a Master Services Agreement and fee-based Order Form with Cube Group’s Cube Operations LLC to use Cube’s platform and MPC wallet for custody and discretionary management of Solana tokens and other potential digital assets, agreeing to a tiered management-fee structure with a minimum monthly payment of $2,500. In a December 19, 2025 announcement, Mangoceuticals unveiled an up to $100 million Solana-focused Digital Asset Treasury strategy under its MULTI-DAT framework, positioning the company as an early institutional adopter within the Solana ecosystem and aiming to generate non-dilutive, yield-driven treasury growth via Solana staking and DeFi participation, while also exploring broader digital asset, tokenized real-world asset, staking, and stablecoin treasury initiatives and reserving the option to tap its existing shelf registration to help fund Solana accumulation and related crypto ventures.

More about Mangoceuticals, Inc.

Mangoceuticals, Inc. is a NASDAQ-listed health and wellness company that develops, markets, and sells men’s wellness products—focused on erectile dysfunction, hair growth, hormone replacement therapies, and weight management—via its MangoRx and PeachesRx secure telemedicine platforms, with prescriptions reviewed by physicians and fulfilled through a partner compounding pharmacy for direct-to-consumer delivery.

Average Trading Volume: 1,447,809

Technical Sentiment Signal: Sell

Current Market Cap: $16.97M

Learn more about MGRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1